These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14727892)

  • 1. Evaluation of Orntide microspheres in a rat animal model and correlation to in vitro release profiles.
    Kostanski JW; Dani BA; Reynolds GA; Bowers CY; DeLuca PP
    AAPS PharmSciTech; 2000 Oct; 1(4):E27. PubMed ID: 14727892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel in vitro release technique for peptide containing biodegradable microspheres.
    Kostanski JW; DeLuca PP
    AAPS PharmSciTech; 2000 Mar; 1(1):E4. PubMed ID: 14727853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the concurrent LHRH antagonist administration with a LHRH superagonist in rats.
    Kostanski JW; Dani BA; Schrier B; DeLuca PP
    Pharm Res; 2000 Apr; 17(4):445-50. PubMed ID: 10870989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.
    Kostanski JW; Thanoo BC; DeLuca PP
    Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist.
    D'Souza SS; Selmin F; Murty SB; Qiu W; Thanoo BC; DeLuca PP
    AAPS PharmSci; 2004 Mar; 6(1):E10. PubMed ID: 15198511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro/in-vivo studies of the biodegradable poly-(D,L-lactide-co-glycolide) microspheres of a novel luteinizing hormone-releasing hormone antagonist for prostate cancer treatment.
    Du L; Mei X; Wang C; Li X; Zhang F; Jin Y
    Anticancer Drugs; 2011 Mar; 22(3):262-72. PubMed ID: 21360849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron-loaded biodegradable microspheres as a nasal sustained delivery system: in vitro/in vivo studies.
    Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
    Pharm Dev Technol; 2010 Jun; 15(3):258-65. PubMed ID: 22716466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of pituitary-gonadal function in male rats after long-term suppression induced by a single injection of microcapsules of LH-RH antagonist cetrorelix (SB-75).
    Pinski J; Yano T; Szepeshazi K; Groot K; Schally AV
    J Androl; 1993; 14(3):164-9. PubMed ID: 8407570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Return to fertility after extended chemical castration with a GnRH antagonist.
    Kostanski JW; Jiang G; Dani BA; Murty SB; Qiu W; Schrier B; Thanoo BC; DeLuca PP
    BMC Cancer; 2001; 1():18. PubMed ID: 11710965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nafarelin controlled release injectable: theoretical clinical plasma profiles from multiple dosing and from mixtures of microspheres containing 2 per cent, 4 per cent and 7 per cent nafarelin.
    Burns RA; Vitale K; Sanders LM
    J Microencapsul; 1990; 7(3):397-413. PubMed ID: 2143531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres.
    Woo BH; Kostanski JW; Gebrekidan S; Dani BA; Thanoo BC; DeLuca PP
    J Control Release; 2001 Aug; 75(3):307-15. PubMed ID: 11489318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB; Goodman J; Thanoo BC; DeLuca PP
    AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.
    Hickey T; Kreutzer D; Burgess DJ; Moussy F
    J Biomed Mater Res; 2002 Aug; 61(2):180-7. PubMed ID: 12007197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
    Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
    Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
    J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.
    Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y
    Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.